A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)

Condition:   Relapsed / Refractory Follicular Lymphoma Intervention:   Drug: TQ-B3525 Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting

Source: ClinicalTrials.gov - March 27, 2020 Category: Research Source Type: clinical trials